Alan S. Louie, Ph.D., IDC Health Insights

Alan S. Louie, Ph.D. Alan S. Louie, Ph.D., Research Director, is responsible for directing the IDC Health Insights Life Sciences Practice. Dr. Louie manages a group of analysts who provide research-based advisory and consulting services for life sciences companies, technology vendors, and IT service providers across the life sciences value chain.  Building on more than 32 years in the industry, Dr. Louie also leads IDC Health Insights' Life Science R&D Strategy and Technology Research service with coverage of innovation and best practices in pharmaceutical R&D and a further emphasis on technology and innovation in clinical development, business analytics, translational research, and precision medicine.


11:20 AM - 11:50 AM

R&D Use Cases Part II

Drug Discovery is a long process that AI technologies and tools are beginning to help shorten.  The speakers in this two-part R&D Use Case session will present information on current projects where they are applying AI.  They will cover the inputs and outcomes, as well as share insights from applying AI  to their discovery projects



  • Kate Hilyard, Ph.D.

    Kate Hilyard, Ph.D. Chief Operating Officer Healx

    The use of AI in accelerating new rare disease drugs towards the clinic
    This use case will discuss how AI enabled us to get from disease selection to clinical candidate selection for fragile X syndrome in 24 months.

    •  How AI and ML predict viable treatment options
    •  The importance of partnership and patient insight – FRAXA Research Foundation example
    • Preclinical proof of concept for fragile X syndrome
    •  Progression to clinical trials

Download Latest Agenda